Literature DB >> 8272596

Inclusion body myositis: new concepts.

E A Sekul1, M C Dalakas.   

Abstract

Entities:  

Mesh:

Year:  1993        PMID: 8272596     DOI: 10.1055/s-2008-1041132

Source DB:  PubMed          Journal:  Semin Neurol        ISSN: 0271-8235            Impact factor:   3.420


× No keyword cloud information.
  8 in total

1.  Intravenous immunoglobulin in patients with anti-GAD antibody-associated neurological diseases and patients with inflammatory myopathies: effects on clinicopathological features and immunoregulatory genes.

Authors:  Marinos C Dalakas
Journal:  Clin Rev Allergy Immunol       Date:  2005-12       Impact factor: 8.667

Review 2.  Immunotherapy of myositis: issues, concerns and future prospects.

Authors:  Marinos C Dalakas
Journal:  Nat Rev Rheumatol       Date:  2010-02-02       Impact factor: 20.543

Review 3.  Inclusion body myositis.

Authors:  Mazen M Dimachkie; Richard J Barohn
Journal:  Neurol Clin       Date:  2014-06-06       Impact factor: 3.806

Review 4.  Inclusion body myositis.

Authors:  M J Garlepp; F L Mastaglia
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-03       Impact factor: 10.154

5.  [PM-Scl antibody positive systemic sclerosis associated with inclusion-body myositis].

Authors:  S Kim; E Genth; T Krieg; N Hunzelmann
Journal:  Z Rheumatol       Date:  2005-10       Impact factor: 1.372

Review 6.  Inclusion body myositis.

Authors:  Mazen M Dimachkie; Richard J Barohn
Journal:  Curr Neurol Neurosci Rep       Date:  2013-01       Impact factor: 5.081

Review 7.  Inclusion body myositis.

Authors:  Mazen M Dimachkie; Richard J Barohn
Journal:  Semin Neurol       Date:  2012-11-01       Impact factor: 3.420

8.  How citation distortions create unfounded authority: analysis of a citation network.

Authors:  Steven A Greenberg
Journal:  BMJ       Date:  2009-07-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.